We found that the novel CRHR1 rs62057073 MDD risk C-allele is predicted to disrupt the binding of the helicase-like transcription factor (HLTF, also known as SMARCA3) and creates a new binding site for the glucocorticoid receptor-alpha (GR-α) (Table 1). This evidence concerns the gene HLTF and major depressive disorder.